Doctor profile · Federal record
Dr. Barbara Goldstein, MD
Rheumatology Physician (CMS: Rheumatology) · Denver, CO
- NPI 1285885095
- Accepts Medicare
- MIPS 93.2 / 100 · 2023
- 20 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
(303) 394-2828
fax (303) 320-0242
Credentials & registration
- NPI registered
- October 2008 — 18 yrs on file
- Profile last updated
- September 7, 2023
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Colorado #50990
- Medicaid
- CO #26056348
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285885095. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
73,291
Distinct HCPCS
10
Medicare allowed
$1,362,629
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 32,720 | 23 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,450 | 33 | $12 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,850 | 44 | $41 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 6,300 | 18 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 6,060 | 82 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,270 | 40 | $31 | |
J9312 |
Injection, rituximab, 10 mg | 3,100 | 15 | $80 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,750 | 16 | $36 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 384 | 171 | $134 | |
J7050 |
Infusion, normal saline solution, 250 cc | 250 | 123 | $1 |
In context: peer comparison
Among 19 peers in Denver Rheumatology Physician, average services per provider: 2,043. This provider delivers 36× the peer median.Open Payments
Industry payments received
All-time total
$3,534
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $2,334.71 | |
| Amgen INC. | 10 | $228.20 | |
| Abbvie INC. | 7 | $164.34 | |
| AstraZeneca Pharmaceuticals Lp | 7 | $131.38 | |
| Lilly USA, LLC | 5 | $113.52 | |
| Novartis Pharmaceuticals Corporation | 4 | $98.95 | |
| Radius Health, INC. | 4 | $76.87 | |
| Ucb, INC. | 3 | $68.65 | |
| Pfizer INC. | 3 | $59.13 | |
| Aurinia Pharma U.S., INC. | 2 | $54.12 | |
| Genentech USA, INC. | 3 | $51.07 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $37.72 | |
| Genzyme Corporation | 2 | $32.32 | |
| Sandoz INC. | 1 | $18.50 | |
| Alvogen INC | 1 | $17.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
949
Patients
316
Total drug cost
$34,617
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 187 | 67 | $2,275 |
| Methotrexate (Methotrexate Sodium) | Brand | 130 | 39 | $7,034 |
| Hydroxychloroquine Sulfate | Generic | 121 | 46 | $11,446 |
| Alendronate Sodium | Generic | 119 | 38 | $1,267 |
| Allopurinol | Generic | 66 | 17 | $1,453 |
| Duloxetine Hcl | Generic | 54 | 26 | $1,476 |
| Meloxicam | Generic | 47 | 15 | $402 |
| Tramadol Hcl | Generic | 43 | 19 | $337 |
| Celecoxib | Generic | 34 | 0 | $2,999 |
| Gabapentin | Generic | 34 | 14 | $1,034 |
Hospital affiliations
Frequently asked questions
What is Dr. Barbara Goldstein's medical specialty?
Dr. Barbara Goldstein practices Rheumatology Physician in Denver, CO.
Where does Dr. Barbara Goldstein practice?
Dr. Barbara Goldstein practices at 7111 E Lowry Blvd Ste 200, Denver, CO 802307360. Office phone: 3033942828.
What is Dr. Barbara Goldstein's NPI?
Dr. Barbara Goldstein's National Provider Identifier (NPI) is 1285885095, issued by NPPES.
Does Dr. Barbara Goldstein accept Medicare assignment?
Yes. Dr. Barbara Goldstein accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Barbara Goldstein commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.